Literature DB >> 28749709

LncRNA HOXA11-AS Exerts Oncogenic Functions by Repressing p21 and miR-124 in Uveal Melanoma.

Qinkang Lu1, Na Zhao1, Guiping Zha1, Huiyun Wang1, Qihu Tong1, Shuanghua Xin1.   

Abstract

Long noncoding RNAs (lncRNAs) have been reported to play vital roles in various human cancers. The aim of this study was to explore the critical role of lncRNA HOXA11-AS in uveal melanoma (UM) progression. Briefly, we found that HOXA11-AS is overexpressed in UM tissues and cells; HOXA11-AS could regulate UM cell growth, invasion, and apoptosis. Mechanistically, RNA immunoprecipitation demonstrated that HOXA11-AS could simultaneously interact with enhancer of zeste homolog 2 (EZH2) to suppress its target p21 protein expression. In addition, we demonstrated that HOXA11-AS functioned as a molecular sponge for miR-124, and overexpression of miR-124 attenuated the proliferation and invasion-promoting effect of HOXA11-AS. Collectively, our findings reveal an oncogenic role for HOXA11-AS in UM tumorigenesis.

Entities:  

Keywords:  HOXA11-AS; long noncoding RNA; uveal melanoma

Mesh:

Substances:

Year:  2017        PMID: 28749709     DOI: 10.1089/dna.2017.3808

Source DB:  PubMed          Journal:  DNA Cell Biol        ISSN: 1044-5498            Impact factor:   3.311


  27 in total

1.  Long non-coding RNA HOXA11-AS accelerates the progression of keloid formation via miR-124-3p/TGFβR1 axis.

Authors:  Jun Jin; Zhen-Hua Jia; Xiao-Hua Luo; Hong-Feng Zhai
Journal:  Cell Cycle       Date:  2019-12-27       Impact factor: 4.534

2.  Expression of long non-coding RNA HOXA11-AS is correlated with progression of laryngeal squamous cell carcinoma.

Authors:  Lingmei Qu; Meng Jin; Like Yang; Chuanhui Sun; Peng Wang; Yushan Li; Linli Tian; Ming Liu; Yanan Sun
Journal:  Am J Transl Res       Date:  2018-02-15       Impact factor: 4.060

3.  HOXA11-AS promotes the migration and invasion of hepatocellular carcinoma cells by inhibiting miR-124 expression by binding to EZH2.

Authors:  Wen-Long Zhang; Ya-Nan Zhao; Zhang-Zhen Shi; Gui-Ying Gu; Dan Cong; Chen Wei; Yuan-Song Bai
Journal:  Hum Cell       Date:  2019-09-06       Impact factor: 4.174

4.  Long non-coding RNA LINC01410 promotes colon cancer cell proliferation and invasion by inhibiting miR-3128.

Authors:  Jihui Luo; Yi Guo; Xiaofei Liu; Xihua Yang; Fangtao Xiao; Meihua Zhou
Journal:  Exp Ther Med       Date:  2018-09-28       Impact factor: 2.447

5.  Long non-coding RNA HOXA11-AS knockout inhibits proliferation and overcomes drug resistance in ovarian cancer.

Authors:  Yuwei Chen; Zhaolei Cui; Qiaoling Wu; Huihui Wang; Hongmei Xia; Yang Sun
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

6.  Downregulated lncRNA HOXA11-AS Affects Trophoblast Cell Proliferation and Migration by Regulating RND3 and HOXA7 Expression in PE.

Authors:  Yetao Xu; Dan Wu; Jie Liu; Shiyun Huang; Qing Zuo; Xi Xia; Ying Jiang; Sailan Wang; Yanzi Chen; Tianjun Wang; Lizhou Sun
Journal:  Mol Ther Nucleic Acids       Date:  2018-05-29       Impact factor: 8.886

Review 7.  Epigenetics and MicroRNAs in Cancer.

Authors:  Alice Ramassone; Sara Pagotto; Angelo Veronese; Rosa Visone
Journal:  Int J Mol Sci       Date:  2018-02-03       Impact factor: 5.923

8.  High expression of lncRNA PVT1 independently predicts poor overall survival in patients with primary uveal melanoma.

Authors:  Haiming Xu; Jingwen Gong; Hui Liu
Journal:  PLoS One       Date:  2017-12-15       Impact factor: 3.240

Review 9.  HOXA11 antisense long noncoding RNA (HOXA11-AS): A promising lncRNA in human cancers.

Authors:  Cheng-Wei Lu; Dan-Dan Zhou; Tian Xie; Ji-Long Hao; Om Prakash Pant; Cheng-Bo Lu; Xiu-Fen Liu
Journal:  Cancer Med       Date:  2018-07-10       Impact factor: 4.452

Review 10.  HOXA11-AS: a novel regulator in human cancer proliferation and metastasis.

Authors:  Jiang-Yang Xue; Chao Huang; Wei Wang; Hai-Bo Li; Ming Sun; Min Xie
Journal:  Onco Targets Ther       Date:  2018-07-27       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.